| 英文名称 | Pexidartinib (Synonyms: PLX-3397) |
|---|---|
| 中文名称 | 5-((5-氯-1H-吡咯并[2,3-b]吡啶-3-基)甲基)-N-((6-(三氟甲基)吡啶-3-基)甲基)吡啶-2-胺 |
| CAS号 | 1029044-16-3 |
| 分子式 | C20H15ClF3N5 |
| 分子量 | 417.81 |
| 英文名称 | Pexidartinib (Synonyms: PLX-3397) |
|---|---|
| 中文名称 | 5-((5-氯-1H-吡咯并[2,3-b]吡啶-3-基)甲基)-N-((6-(三氟甲基)吡啶-3-基)甲基)吡啶-2-胺 |
| CAS号 | 1029044-16-3 |
| 分子式 | C20H15ClF3N5 |
| 分子量 | 417.81 |
Pexidartinib (PLX-3397) is a potent, orally active, selective, and ATP-competitive colony stimulating factor 1 receptor (CSF1R or M-CSFR) and c-Kit inhibitor, with IC50s of 20 and 10 nM, respectively. Pexidartinib (PLX-3397) exhibits 10- to 100-fold selectivity for c-Kit and CSF1R over other related kinases. Pexidartinib (PLX-3397) induces cell apoptosis and has anti-tumor activity.